Ankaflavin ameliorates steatotic liver ischemia-reperfusion injury in mice

Hepatobiliary and Pancreatic Diseases International

Volumn 14, Issue 6, 2015, Pages 619-625

  Yang, Hao Jun ^a,b   Tang, Li Ming ^b   Zhou, Xian Ju ^b   Qian, Jun ^b   Zhu, Jie ^b   Lu, Ling ^a   Wang, Xue Hao ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

ankaflavin; ischemia reperfusion; Kupffer cells; steatotic liver

Indexed keywords

AMINOTRANSFERASE; ANKAFLAVIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIVER PROTECTIVE AGENT; QUERCETIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; BIOLOGICAL MARKER; CYTOKINE; RIBOFLAVIN DERIVATIVE;

AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BLOOD SAMPLING; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; KUPFFER CELL; LIPID DIET; LIVER CELL; LIVER ISCHEMIA; LIVER PROTECTION; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; PILOT STUDY; PROTEIN EXPRESSION; REPERFUSION INJURY; ANIMAL; BLOOD; C57BL MOUSE; CELL PROTECTION; COMPLICATION; DISEASE MODEL; DRUG EFFECTS; LIVER; MALE; METABOLISM; NON-ALCOHOLIC FATTY LIVER DISEASE; PATHOLOGY; SURGERY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; APOPTOSIS; BIOMARKERS; CELL PROLIFERATION; CYTOKINES; CYTOPROTECTION; DISEASE MODELS, ANIMAL; FLAVINS; HEPATOCYTES; KUPFFER CELLS; LIVER; MALE; MICE, INBRED C57BL; NON-ALCOHOLIC FATTY LIVER DISEASE; OXIDATIVE STRESS; REPERFUSION INJURY;

EID: 84951816077     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1499-3872(15)60361-7     Document Type: Article

References (30)

1. BW Smith, LA Adams Non-alcoholic fatty liver disease Crit Rev Clin Lab Sci 48 2011 97 113
2. A Said Non-alcoholic fatty liver disease and liver transplantation: outcomes and advances World J Gastroenterol 19 2013 9146 9155
3. JA Perez-Daga, J Santoyo, MA Suárez, JA Fernández-Aguilar, C Ramírez, A Rodríguez-Cañete et al. Influence of degree of hepatic steatosis on graft function and postoperative complications of liver transplantation Transplant Proc 38 2006 2468 2470
4. L Llacuna, M Marí, JM Lluis, C García-Ruiz, JC Fernández-Checa, A Morales Reactive oxygen species mediate liver injury through parenchymal nuclear factor-kappaB inactivation in prolonged ischemia/reperfusion Am J Pathol 174 2009 1776 1785
5. A Leroux, G Ferrere, V Godie, F Cailleux, ML Renoud, F Gaudin et al. Toxic lipids stored by Kupffer cells correlates with their pro-inflammatory phenotype at an early stage of steatohepatitis J Hepatol 57 2012 141 149
6. T Tamura, T Kondo, S Pak, Y Nakano, S Murata, K Fukunaga et al. Interaction between Kupffer cells and platelets in the early period of hepatic ischemia-reperfusion injury-an in vivo study J Surg Res 178 2012 443 451
7. H Bruns, I Watanpour, MM Gebhard, C Flechtenmacher, U Galli, H Schulze-Bergkamen et al. Glycine and taurine equally prevent fatty livers from Kupffer cell-dependent injury: an in vivo microscopy study Microcirculation 18 2011 205 213
8. CL Lee, JY Wen, YW Hsu, TM Pan Monascus-fermented yellow pigments monascin and ankaflavin showed antiobesity effect via the suppression of differentiation and lipogenesis in obese rats fed a high-fat diet J Agric Food Chem 61 2013 1493 1500
9. WH Hsu, BH Lee, TM Pan Red mold dioscorea-induced G2/M arrest and apoptosis in human oral cancer cells J Sci Food Agric 90 2010 2709 2715
10. LC Hsu, YH Liang, YW Hsu, YH Kuo, TM Pan Anti-inflammatory properties of yellow and orange pigments from Monascus purpureus NTU 568 J Agric Food Chem 61 2013 2796 2802
11. CL Lee, TY Tsai, JJ Wang, TM Pan In vivo hypolipidemic effects and safety of low dosage Monascus powder in a hamster model of hyperlipidemia Appl Microbiol Biotechnol 70 2006 533 540
12. CL Lee, YP Hung, YW Hsu, TM Pan Monascin and ankaflavin have more anti-atherosclerosis effect and less side effect involving increasing creatinine phosphokinase activity than monacolin K under the same dosages J Agric Food Chem 61 2013 143 150
13. WH Hsu, TH Chen, BH Lee, YW Hsu, TM Pan Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice Food Chem Toxicol 64 2014 94 103
14. JD Ellett, ZP Evans, C Atkinson, MG Schmidt, RG Schnellmann, KD Chavin Toll-like receptor 4 is a key mediator of murine steatotic liver warm ischemia/reperfusion injury Liver Transpl 15 2009 1101 1109
15. R Jiang, Y Xia, J Li, L Deng, L Zhao, J Shi et al. High expression levels of IKKalpha and IKKbeta are necessary for the malignant properties of liver cancer Int J Cancer 126 2010 1263 1274
16. J Fang, H Qin, T Seki, H Nakamura, K Tsukigawa, T Shin et al. Therapeutic potential of pegylated hemin for reactive oxygen species-related diseases via induction of heme oxygenase-1: results from a rat hepatic ischemia/reperfusion injury model J Pharmacol Exp Ther 339 2011 779 789
17. R Stienstra, F Saudale, C Duval, S Keshtkar, JE Groener, N van Rooijen et al. Kupffer cells promote hepatic steatosis via interleukin-1beta-dependent suppression of peroxisome proliferator-activated receptor alpha activity Hepatology 51 2010 511 522
18. H Taniai, IN Hines, S Bharwani, RE Maloney, Y Nimura, B Gao et al. Susceptibility of murine periportal hepatocytes to hypoxia-reoxygenation: role for NO and Kupffer cell-derived oxidants Hepatology 39 2004 1544 1552
19. EL de Graaf, J Kench, P Dilworth, NA Shackel, SI Strasser, D Joseph et al. Grade of deceased donor liver macrovesicular steatosis impacts graft and recipient outcomes more than the Donor Risk Index J Gastroenterol Hepatol 27 2012 540 546
20. I Ben Mosbah, J Roselló-Catafau, I Alfany-Fernandez, A Rimola, PP Parellada, MT Mitjavila et al. Addition of carvedilol to University Wisconsin solution improves rat steatotic and non-steatotic liver preservation Liver Transpl 16 2010 163 171
21. M Selzner, PA Clavien Fatty liver in liver transplantation and surgery Semin Liver Dis 21 2001 105 113
22. M Vairetti, A Ferrigno, F Carlucci, A Tabucchi, V Rizzo, E Boncompagni et al. Subnormothermic machine perfusion protects steatotic livers against preservation injury: a potential for donor pool increase? Liver Transpl 15 2009 20 29
23. XY Luo, T Takahara, J Hou, K Kawai, T Sugiyama, K Tsukada et al. Theaflavin attenuates ischemia-reperfusion injury in a mouse fatty liver model Biochem Biophys Res Commun 417 2012 287 293
24. CP Lin, YL Lin, PH Huang, HS Tsai, YH Chen Inhibition of endothelial adhesion molecule expression by Monascus purpureus-fermented rice metabolites, monacolin K, ankaflavin, and monascin J Sci Food Agric 91 2011 1751 1758
25. WH Hsu, BH Lee, YC Huang, YW Hsu, TM Pan Ankaflavin, a novel Nrf-2 activator for attenuating allergic airway inflammation Free Radic Biol Med 53 2012 1643 1651
26. H Kudo, Y Yata, T Takahara, K Kawai, Y Nakayama, M Kanayama et al. Telmisartan attenuates progression of steatohepatitis in mice: role of hepatic macrophage infiltration and effects on adipose tissue Liver Int 29 2009 988 996
27. K Teramoto, JL Bowers, JB Kruskal, ME Clouse Hepatic microcirculatory changes after reperfusion in fatty and normal liver transplantation in the rat Transplantation 56 1993 1076 1082
28. R Thieringer, JE Fenyk-Melody, CB Le Grand, BA Shelton, PA Detmers, EP Somers et al. Activation of peroxisome proliferator-activated receptor gamma does not inhibit IL-6 or TNF-alpha responses of macrophages to lipopolysaccharide in vitro or in vivo J Immunol 164 2000 1046 1054
29. YJ Wu, Q Ling, XH Zhou, Y Wang, HY Xie, JR Yu et al. Urinary trypsin inhibitor attenuates hepatic ischemia-reperfusion injury by reducing nuclear factor-kappa B activation Hepatobiliary Pancreat Dis Int 8 2009 53 58
30. AM Diehl Nonalcoholic steatosis and steatohepatitis IV Nonalcoholic fatty liver disease abnormalities in macrophage function and cytokines. Am J Physiol Gastrointest Liver Physiol 282 2002 G1 G5